JD Health International Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	73,441	58,160	53,530	46,736	30,682
Revenue Growth (YoY)	26.27%	8.65%	14.54%	52.32%	58.30%
Cost of Revenue	55,242	44,851	41,665	36,845	23,485
Gross Profit	18,199	13,309	11,865	9,892	7,197
Selling, General & Admin	12,624	10,499	9,938	8,871	7,670
Research & Development	1,634	1,330	1,226	1,067	892.91
Operating Expenses	14,401	12,146	11,234	10,037	8,601
Operating Income	3,798	1,163	630.85	-145.12	-1,404
Interest Expense	-11.1	-8.19	-9.49	-9.1	-6
Interest & Investment Income	1,538	1,961	1,949	864.27	457.57
Earnings From Equity Investments	-64.05	-85.53	-70.76	-96.76	-94.17
Other Non Operating Income (Expenses)	769.61	1,767	193.71	82.52	145.15
EBT Excluding Unusual Items	6,030	4,797	2,693	695.81	-901.49
Pretax Income	6,030	4,797	2,693	695.81	-901.49
Income Tax Expense	662.89	639.66	550.47	312.58	171.33
Earnings From Continuing Operations	5,367	4,157	2,143	383.23	-1,073
Minority Interest in Earnings	8.3	4.83	-1.04	-3.12	-0.69
Net Income	5,375	4,162	2,142	380.11	-1,074
Net Income to Common	5,375	4,162	2,142	380.11	-1,074
Net Income Growth	29.16%	94.31%	463.49%	-	-
Shares Outstanding (Basic)	3,163	3,143	3,124	3,107	3,095
Shares Outstanding (Diluted)	3,196	3,160	3,164	3,144	3,095
Shares Change (YoY)	1.14%	-0.12%	0.62%	1.60%	40.13%
EPS (Basic)	1.70	1.32	0.69	0.12	-0.35
EPS (Diluted)	1.68	1.32	0.68	0.12	-0.35
EPS Growth	27.27%	94.12%	466.67%	-	-
Free Cash Flow	10,174	4,294	4,544	5,865	2,929
Free Cash Flow Per Share	3.18	1.36	1.44	1.86	0.95
Gross Margin	24.78%	22.88%	22.17%	21.16%	23.46%
Operating Margin	5.17%	2.00%	1.18%	-0.31%	-4.58%
Profit Margin	7.32%	7.16%	4.00%	0.81%	-3.50%
Free Cash Flow Margin	13.85%	7.38%	8.49%	12.55%	9.54%
EBITDA	4,078	1,315	794.92	-60.93	-1,372
EBITDA Margin	5.55%	2.26%	1.49%	-0.13%	-4.47%
D&A For EBITDA	279.99	151.95	164.07	84.19	32.41
EBIT	3,798	1,163	630.85	-145.12	-1,404
EBIT Margin	5.17%	2.00%	1.18%	-0.31%	-4.58%
Effective Tax Rate	10.99%	13.34%	20.44%	44.92%	-
Advertising Expenses	1,934	1,564	1,305	922.22	1,290

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.